PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NAPRx®

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

NAPSR Announces Pharmaceutical Representative Magazine Subscription - A 12-month subscription to Pharmaceutical Representative magazine is now included to all one year members of the National Association of Pharmaceutical Sales Representatives!
NAPSR Announces Pharmaceutical Representative Magazine Subscription

 

NewswireToday - /newswire/ - Washington, DC, United States, 2006/09/29 - A 12-month subscription to Pharmaceutical Representative magazine is now included to all one year members of the National Association of Pharmaceutical Sales Representatives!.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pharmaceutical Representative is the industry's leading source of ongoing sales insight and development. It provides the essential skills sales representatives need to maximize their access and value to healthcare providers. It also enhances the expertise of trainers and managers so they can support the professional growth of their sales force.

Pharmaceutical Representative is the only magazine targeting pharmaceutical reps. With a circulation of more than 73,500, Pharmaceutical Representative is the industries magazine that delivers sales training and education directly to sales representatives, managers, and trainers at nearly 90 leading pharmaceutical companies.

If you are seeking a career in pharmaceutical sales it is important to obtain accredited pharmaceutical sales training (CNPR® Program). You can find several books out there will help with your resume and cover letter but will not provide you with the necessary job skill sets that pharmaceutical employers prefer. The NAPSR® offers accredited entry level pharmaceutical sales training utilized by hundred of colleges and pharmaceutical companies nationwide. The CNPR® program provides candidates with the skills sets that attract pharmaceutical employers and comprehensive industry training which will enhance anyone's pharmaceutical sales career. To effectively detail physicians you need to understand the fundamentals of pharmacology as well as some understanding of the medical industry. The NAPSR® (CNPR® Program) is presented in a way that is easy to comprehend while being user friendly. If you are looking to enter a new career in pharmaceutical sales make your job search become much easier by acquiring the skills sets sought after by pharmaceutical companies and obtain your CNPR® as soon as possible.

A (CNPR®) is a federally trademarked certification mark conferred by the National Association of Pharmaceutical Sales Representatives® (NAPSR®) for those who want to gain entry into the pharmaceutical industry and for current pharmaceutical representatives. The CNPR® examination is dedicated to increasing the professional level of NAPSR® members and to developing meaningful and ethical standards fully accepted by its members and members of the pharmaceutical community. The goal of the training program is to develop education in clinical pharmacology, physiology and medical terminology. This knowledge will greatly enhance an individuals understanding of the pharmaceutical industry and its selling process as well as enhance an applicants hiring potential.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NAPRx®

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


NAPSR Announces Pharmaceutical Representative Magazine Subscription

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Brad Sullivan - NAPSRonline.org 
1-800-913-0701 x104 questions[.]napsronline.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NAPRx® securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NAPRx® / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)